Quarter Ended

Six Months Ended

December 31,

2020

2019

2020

2019

Earnings per share – basic:

Net earnings, including noncontrolling interest

$

46,144

119,622

79,538

134,018

Less net earnings attributable to noncontrolling interest

(130

)

-

(130

)

-

Net earnings attributable to Bio-Techne

$

46,274

$

119,622

$

79,668

$

134,018

Income allocated to participating securities

(37

)

(172

)

(50

)

(258

)

Income available to common shareholders

$

46,237

$

119,450

$

79,618

$

133,760

Weighted-average shares outstanding – basic

38,691

38,167

38,614

38,100

Earnings per share – basic

$

1.20

$

3.13

$

2.06

$

3.51

Earnings per share – diluted:

Net earnings, including noncontrolling interest

$

46,144

$

119,622

$

79,538

$

134,018

Less net earnings attributable to noncontrolling interest

(130

)

-

(130

)

-

Net earnings attributable to Bio-Techne

$

46,274

$

119,622

$

79,668

$

134,018

Income allocated to participating securities

(37

)

(172

)

(50

)

(258

)

Income available to common shareholders

$

46,237

$

119,450

$

79,618

$

133,760

Weighted-average shares outstanding – basic

38,691

38,167

38,614

38,100

Dilutive effect of stock options and restricted stock units

1,566

1,383

1,521

1,270

Weighted-average common shares outstanding – diluted

40,257

39,550

40,135

39,370

Earnings per share – diluted

$

1.15

$

3.02

$

1.98

$

3.40